Phillip Christopher is an investment professional with over 12 years of experience across private equity, mergers and acquisitions, and capital markets. He has led a range of strategic investments and provided board level support, corporate and commercial advice to investee companies.
Mr Christopher has been the investment director of HGL since May 2021, where he has been responsible for advising and guiding private investments including BLC Cosmetics prior to its acquisition by Cellmid. He also spent 6 years at Alceon Group where he was a director in the private equity team which made investments in e-commerce and proprietary brand-based businesses. Prior to that, Mr Christopher was a member of the investment banking division of Goldman Sachs.
